312 related articles for article (PubMed ID: 31515764)
41. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
Catassi G; D'Arcangelo G; Norsa L; Bramuzzo M; Hojsak I; Kolho KL; Romano C; Gasparetto M; Di Giorgio A; Hussey S; Yerushalmy-Feler A; Turner D; Matar M; Weiss B; Karoliny A; Alvisi P; Tzivinikos C; Aloi M
Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37768032
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
43. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
44. Primary sclerosing cholangitis: a clinical update.
Williamson KD; Chapman RW
Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
[TBL] [Abstract][Full Text] [Related]
45. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
Ngu JH; Gearry RB; Wright AJ; Stedman CA
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for primary sclerosing cholangitis.
Boonstra K; de Vries EM; van Geloven N; van Erpecum KJ; Spanier M; Poen AC; van Nieuwkerk CM; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; Beuers U; Ponsioen CY;
Liver Int; 2016 Jan; 36(1):84-91. PubMed ID: 26077553
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
[TBL] [Abstract][Full Text] [Related]
49. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
50. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
Lunder AK; Hov JR; Borthne A; Gleditsch J; Johannesen G; Tveit K; Viktil E; Henriksen M; Hovde Ø; Huppertz-Hauss G; Høie O; Høivik ML; Monstad I; Solberg IC; Jahnsen J; Karlsen TH; Moum B; Vatn M; Negård A
Gastroenterology; 2016 Oct; 151(4):660-669.e4. PubMed ID: 27342213
[TBL] [Abstract][Full Text] [Related]
52. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.
Liu K; Strasser SI; Koorey DJ; Leong RW; Solomon M; McCaughan GW
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):949-960. PubMed ID: 28627935
[TBL] [Abstract][Full Text] [Related]
53. Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population.
Nardelli MJ; Bittencourt PL; Cançado GGL; Faria LC; Villela-Nogueira CA; Rotman V; Silva de Abreu E; Maria Farage Osório F; Evangelista AS; Sampaio Costa Mendes L; Ferraz de Campos Mazo D; Hyppolito EB; de Souza Martins A; Codes L; Signorelli IV; Perez Medina Gomide G; Agoglia L; Alexandra Pontes Ivantes C; Ferreira de Almeida E Borges V; Coral GP; Eulira Fontes Rezende R; Lucia Gomes Ferraz M; Raquel Benedita Terrabuio D; Luiz Rachid Cançado E; Couto CA
Can J Gastroenterol Hepatol; 2021; 2021():7746401. PubMed ID: 34805028
[TBL] [Abstract][Full Text] [Related]
54. Immune-mediated diseases in primary sclerosing cholangitis.
Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP
Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972
[TBL] [Abstract][Full Text] [Related]
58. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
Singh H; Balouch F; Noble C; Lewindon P
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.
Kumagai J; Taida T; Ogasawara S; Nakagawa T; Iino Y; Shingyoji A; Ishikawa K; Akizue N; Yamato M; Takahashi K; Ohta Y; Hamanaka S; Okimoto K; Nakamura M; Ohyama H; Saito K; Kusakabe Y; Maruoka D; Yasui S; Matsumura T; Sugiyama H; Sakai Y; Mikata R; Arai M; Katsuno T; Tsuyuguchi T; Kato N
PLoS One; 2018; 13(12):e0209352. PubMed ID: 30571774
[TBL] [Abstract][Full Text] [Related]
60. PSC, AIH and overlap syndrome in inflammatory bowel disease.
Trivedi PJ; Chapman RW
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):420-36. PubMed ID: 22306055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]